Difference between revisions of "Part:BBa K2534003:Design"
Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K2534003 short</partinfo> | <partinfo>BBa_K2534003 short</partinfo> | ||
+ | |||
+ | |||
+ | miRNA-134 5p has been discovered to function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling. | ||
+ | [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] worked to do lentiviral transfection of that part into colorectal cancer cell line RKO to induce regulatory apoptosis as well as to investigate it's immune modulatory effect on TLR-9. | ||
+ | [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] have characterized this part considering it's apoptotic effect of RKO cell lines. | ||
+ | |||
+ | For further information about demonstration of its apoptotic effect, please visit our results page | ||
+ | http://2018.igem.org/Team:AFCM-Egypt/Demonstrate | ||
+ | |||
+ | |||
+ | https://static.igem.org/mediawiki/parts/5/51/Chmir134afcm.png | ||
+ | |||
<partinfo>BBa_K2534003 SequenceAndFeatures</partinfo> | <partinfo>BBa_K2534003 SequenceAndFeatures</partinfo> | ||
Line 7: | Line 19: | ||
===Design Notes=== | ===Design Notes=== | ||
− | IDT | + | This part has been synthesized through IDT offer |
− | + | ||
===Source=== | ===Source=== | ||
− | + | http://2018.igem.org/Team:AFCM-Egypt/Bioinformatics_Page_link | |
− | + | ||
− | + |
Revision as of 12:19, 17 October 2018
miRNA 134 5p
miRNA-134 5p has been discovered to function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.
[http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] worked to do lentiviral transfection of that part into colorectal cancer cell line RKO to induce regulatory apoptosis as well as to investigate it's immune modulatory effect on TLR-9.
[http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] have characterized this part considering it's apoptotic effect of RKO cell lines.
For further information about demonstration of its apoptotic effect, please visit our results page http://2018.igem.org/Team:AFCM-Egypt/Demonstrate
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
This part has been synthesized through IDT offer
Source
http://2018.igem.org/Team:AFCM-Egypt/Bioinformatics_Page_link